| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ER retention sequence binding | 6.01e-08 | 5 | 211 | 4 | GO:0046923 | |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | IL13RA2 OR11L1 OR5I1 OR10J6P GPRC5C TSHR OR2B11 GPR83 MET ADORA3 PTPRD ABCC8 OR8B12 TAS2R40 KIT OR9A2 CCR10 OR2F2 IL31RA HTR2A OR11H4 OR10Q1 OR5M11 ACKR4 GRM4 AR OR6P1 OR6N1 OR52E2 LHCGR OR52A5 TLR3 OR56A5 OR2Y1 LGR6 EPHA7 FCMR | 8.51e-08 | 1353 | 211 | 37 | GO:0004888 |
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | OR11L1 OR5I1 OR10J6P GPRC5C TSHR OR2B11 GPR83 ADORA3 OR8B12 TAS2R40 OR9A2 CCR10 OR2F2 HTR2A OR11H4 OR10Q1 OR5M11 ACKR4 GRM4 AR OR6P1 OR6N1 OR52E2 LHCGR OR52A5 OR56A5 OR2Y1 LGR6 | 2.15e-07 | 884 | 211 | 28 | GO:0004930 |
| GeneOntologyMolecularFunction | KDEL sequence binding | 1.16e-06 | 3 | 211 | 3 | GO:0005046 | |
| GeneOntologyMolecularFunction | pyrimidine nucleotide-sugar transmembrane transporter activity | 3.77e-06 | 11 | 211 | 4 | GO:0015165 | |
| GeneOntologyMolecularFunction | nucleotide-sugar transmembrane transporter activity | 1.12e-05 | 14 | 211 | 4 | GO:0005338 | |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | ABCA12 SLCO1B3 SLC35D1 SLC38A2 ABCC8 SLC35A2 ABCC2 SLC35A5 IPO8 SLC35D2 ABCC11 SLC7A6 SLCO1B7 SLC6A2 SLC7A8 SLC32A1 ATP2C1 | 1.36e-05 | 477 | 211 | 17 | GO:0022804 |
| GeneOntologyMolecularFunction | olfactory receptor activity | OR11L1 OR5I1 OR10J6P OR2B11 OR8B12 OR9A2 OR2F2 OR11H4 OR10Q1 OR5M11 OR6P1 OR6N1 OR52E2 OR52A5 OR56A5 OR2Y1 | 1.49e-05 | 431 | 211 | 16 | GO:0004984 |
| GeneOntologyMolecularFunction | transporter activity | ABCA12 ATP8A2 PEX1 SLCO1B3 SLC35D1 SLC38A2 KCNH1 ABCC8 SCN4A SLC35A2 PKD2 KCNS3 TRPV3 ABCC2 SEC61A1 SLC35A5 CACNA1F CACNA1S IPO8 SLC35D2 ABCC11 PANX2 SLC7A6 SLCO1B7 SLC6A2 SLC7A8 SLC32A1 SEC61A2 ATP2C1 SLC25A52 TMC5 | 1.50e-05 | 1289 | 211 | 31 | GO:0005215 |
| GeneOntologyMolecularFunction | signal sequence binding | 1.57e-05 | 51 | 211 | 6 | GO:0005048 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | ABCA12 SLCO1B3 SLC35D1 SLC38A2 KCNH1 ABCC8 SCN4A SLC35A2 PKD2 KCNS3 TRPV3 ABCC2 SEC61A1 SLC35A5 CACNA1F CACNA1S IPO8 SLC35D2 ABCC11 PANX2 SLC7A6 SLCO1B7 SLC6A2 SLC7A8 SLC32A1 SEC61A2 ATP2C1 SLC25A52 TMC5 | 1.96e-05 | 1180 | 211 | 29 | GO:0022857 |
| GeneOntologyMolecularFunction | ATP-dependent activity | MYO5A ABCA12 ATP8A2 PEX1 SMC5 MYO5C ACSL4 ABCC8 ABCC2 DYNC1H1 IPO8 DYNC2H1 UBA2 ABCC11 BTAF1 ATP2C1 SLFN13 SLFN11 HELLS | 3.00e-05 | 614 | 211 | 19 | GO:0140657 |
| GeneOntologyMolecularFunction | nucleobase-containing compound transmembrane transporter activity | 3.66e-05 | 59 | 211 | 6 | GO:0015932 | |
| GeneOntologyMolecularFunction | UDP-glucuronic acid transmembrane transporter activity | 1.11e-04 | 2 | 211 | 2 | GO:0005461 | |
| GeneOntologyMolecularFunction | UDP-N-acetylgalactosamine transmembrane transporter activity | 1.11e-04 | 2 | 211 | 2 | GO:0005463 | |
| GeneOntologyMolecularFunction | oxysterol 7-alpha-hydroxylase activity | 1.11e-04 | 2 | 211 | 2 | GO:0008396 | |
| GeneOntologyMolecularFunction | dystroglycan binding | 2.39e-04 | 12 | 211 | 3 | GO:0002162 | |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | SLCO1B3 SLC35D1 SLC38A2 SLC35A2 SLC35A5 SLC35D2 SLC7A6 SLCO1B7 SLC6A2 SLC7A8 SLC32A1 | 3.26e-04 | 296 | 211 | 11 | GO:0015291 |
| GeneOntologyMolecularFunction | 24-hydroxycholesterol 7alpha-hydroxylase activity | 3.31e-04 | 3 | 211 | 2 | GO:0033782 | |
| GeneOntologyMolecularFunction | antiporter activity | 6.71e-04 | 138 | 211 | 7 | GO:0015297 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | ABCA12 ATP8A2 PEX1 SMC5 ABCC8 ABCC2 DYNC1H1 DYNC2H1 ABCC11 BTAF1 ATP2C1 SLFN13 SLFN11 | 8.68e-04 | 441 | 211 | 13 | GO:0016887 |
| GeneOntologyMolecularFunction | ATPase-coupled transmembrane transporter activity | 1.06e-03 | 109 | 211 | 6 | GO:0042626 | |
| GeneOntologyMolecularFunction | ubiquitin-like protein-specific endopeptidase activity | 1.09e-03 | 5 | 211 | 2 | GO:0070137 | |
| GeneOntologyMolecularFunction | SUMO-specific endopeptidase activity | 1.09e-03 | 5 | 211 | 2 | GO:0070139 | |
| GeneOntologyMolecularFunction | UDP-N-acetylglucosamine transmembrane transporter activity | 1.09e-03 | 5 | 211 | 2 | GO:0005462 | |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | SLCO1B3 SLC35D1 SLC38A2 ABCC2 SLC35D2 ABCC11 SLC7A6 SLCO1B7 SLC7A8 SLC32A1 | 1.16e-03 | 293 | 211 | 10 | GO:0008514 |
| GeneOntologyMolecularFunction | protein-hormone receptor activity | 1.54e-03 | 22 | 211 | 3 | GO:0016500 | |
| GeneOntologyMolecularFunction | carboxylic acid transmembrane transporter activity | 1.65e-03 | 207 | 211 | 8 | GO:0046943 | |
| GeneOntologyMolecularFunction | organic acid transmembrane transporter activity | 1.70e-03 | 208 | 211 | 8 | GO:0005342 | |
| GeneOntologyMolecularFunction | ABC-type transporter activity | 1.77e-03 | 49 | 211 | 4 | GO:0140359 | |
| GeneOntologyMolecularFunction | organic cation transmembrane transporter activity | 1.87e-03 | 83 | 211 | 5 | GO:0015101 | |
| GeneOntologyMolecularFunction | syntaxin-1 binding | 2.00e-03 | 24 | 211 | 3 | GO:0017075 | |
| GeneOntologyBiologicalProcess | detection of stimulus | OR11L1 OR5I1 ATP8A2 OR10J6P OR2B11 JUP NOD1 PKD2 OR8B12 TAS2R40 KIT OR9A2 CACNA1F OR2F2 HTR2A OR11H4 OR10Q1 OR5M11 OR6P1 OR6N1 OR52E2 OR52A5 OR56A5 OR2Y1 | 2.89e-07 | 722 | 207 | 24 | GO:0051606 |
| GeneOntologyBiologicalProcess | protein localization to endoplasmic reticulum | 3.04e-07 | 90 | 207 | 9 | GO:0070972 | |
| GeneOntologyBiologicalProcess | detection of stimulus involved in sensory perception | OR11L1 OR5I1 ATP8A2 OR10J6P OR2B11 OR8B12 TAS2R40 KIT OR9A2 CACNA1F OR2F2 HTR2A OR11H4 OR10Q1 OR5M11 OR6P1 OR6N1 OR52E2 OR52A5 OR56A5 OR2Y1 | 4.51e-07 | 582 | 207 | 21 | GO:0050906 |
| GeneOntologyBiologicalProcess | SRP-dependent cotranslational protein targeting to membrane, translocation | 6.68e-07 | 8 | 207 | 4 | GO:0006616 | |
| GeneOntologyBiologicalProcess | pyrimidine nucleotide-sugar transmembrane transport | 4.58e-06 | 12 | 207 | 4 | GO:0090481 | |
| GeneOntologyBiologicalProcess | SRP-dependent cotranslational protein targeting to membrane | 6.54e-06 | 27 | 207 | 5 | GO:0006614 | |
| GeneOntologyBiologicalProcess | nucleotide-sugar transmembrane transport | 6.56e-06 | 13 | 207 | 4 | GO:0015780 | |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception of smell | OR11L1 OR5I1 OR10J6P OR2B11 OR8B12 OR9A2 OR2F2 OR11H4 OR10Q1 OR5M11 OR6P1 OR6N1 OR52E2 OR52A5 OR56A5 OR2Y1 | 8.09e-06 | 432 | 207 | 16 | GO:0050911 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception | OR11L1 OR5I1 OR10J6P OR2B11 OR8B12 TAS2R40 OR9A2 OR2F2 OR11H4 OR10Q1 OR5M11 OR6P1 OR6N1 OR52E2 OR52A5 OR56A5 OR2Y1 | 8.63e-06 | 485 | 207 | 17 | GO:0050907 |
| GeneOntologyBiologicalProcess | G protein-coupled receptor signaling pathway | OR11L1 OR5I1 OR10J6P LRRK2 GPRC5C TSHR OR2B11 GPR83 MET ADORA3 OR8B12 TAS2R40 OR9A2 CCR10 OR2F2 HTR2A OR11H4 OR10Q1 MUC19 OR5M11 ACKR4 GRM4 AR OR6P1 OR6N1 OR52E2 LHCGR OR52A5 OR56A5 OR2Y1 LGR6 PDCL | 9.72e-06 | 1395 | 207 | 32 | GO:0007186 |
| GeneOntologyBiologicalProcess | sensory perception | OR11L1 MYO5A OR5I1 ATP8A2 OR10J6P GPRC5C OR2B11 ULK4 OR8B12 TAS2R40 KIT OR9A2 CACNA1F OR2F2 HTR2A OR11H4 OR10Q1 BBS5 OR5M11 OR6P1 OR6N1 CEMIP OR52E2 OR52A5 OR56A5 OR2Y1 PDCL | 1.02e-05 | 1072 | 207 | 27 | GO:0007600 |
| GeneOntologyBiologicalProcess | endoplasmic reticulum organization | 1.25e-05 | 107 | 207 | 8 | GO:0007029 | |
| GeneOntologyBiologicalProcess | intracellular protein transmembrane transport | 1.33e-05 | 31 | 207 | 5 | GO:0065002 | |
| GeneOntologyBiologicalProcess | cotranslational protein targeting to membrane | 1.57e-05 | 32 | 207 | 5 | GO:0006613 | |
| GeneOntologyBiologicalProcess | organic cation transport | SLC38A2 ADORA3 SLC35F3 SCN4A SLC7A6 SLC6A2 SLC7A8 SLC32A1 NISCH | 1.62e-05 | 145 | 207 | 9 | GO:0015695 |
| GeneOntologyBiologicalProcess | carboxylic acid transport | SLCO1B3 SLC35D1 ACSL4 SLC38A2 STXBP1 ABCC8 ABCC2 SLC35D2 ABCC11 CYP4F2 SLC7A6 SLCO1B7 SLC7A8 SLC32A1 LHCGR | 1.80e-05 | 410 | 207 | 15 | GO:0046942 |
| GeneOntologyBiologicalProcess | organic acid transport | SLCO1B3 SLC35D1 ACSL4 SLC38A2 STXBP1 ABCC8 ABCC2 SLC35D2 ABCC11 CYP4F2 SLC7A6 SLCO1B7 SLC7A8 SLC32A1 LHCGR | 1.91e-05 | 412 | 207 | 15 | GO:0015849 |
| GeneOntologyBiologicalProcess | sensory perception of smell | OR11L1 OR5I1 OR10J6P OR2B11 OR8B12 OR9A2 OR2F2 OR11H4 OR10Q1 OR5M11 OR6P1 OR6N1 OR52E2 OR52A5 OR56A5 OR2Y1 | 2.01e-05 | 465 | 207 | 16 | GO:0007608 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus | OR11L1 OR5I1 OR10J6P OR2B11 OR8B12 TAS2R40 OR9A2 OR2F2 OR11H4 OR10Q1 OR5M11 OR6P1 OR6N1 OR52E2 OR52A5 OR56A5 OR2Y1 | 2.33e-05 | 524 | 207 | 17 | GO:0009593 |
| GeneOntologyBiologicalProcess | sensory perception of chemical stimulus | OR11L1 OR5I1 OR10J6P OR2B11 OR8B12 TAS2R40 OR9A2 OR2F2 OR11H4 OR10Q1 OR5M11 OR6P1 OR6N1 OR52E2 OR52A5 OR56A5 OR2Y1 | 4.00e-05 | 547 | 207 | 17 | GO:0007606 |
| GeneOntologyBiologicalProcess | organic anion transport | SLCO1B3 SLC35D1 ACSL4 SLC38A2 STXBP1 ABCC8 SLC35A2 ABCC2 SLC35D2 ABCC11 CYP4F2 SLC7A6 SLCO1B7 SLC7A8 SLC32A1 LHCGR | 6.80e-05 | 515 | 207 | 16 | GO:0015711 |
| GeneOntologyBiologicalProcess | protein retention in ER lumen | 8.00e-05 | 9 | 207 | 3 | GO:0006621 | |
| GeneOntologyBiologicalProcess | glutamate secretion, neurotransmission | 8.00e-05 | 9 | 207 | 3 | GO:0061535 | |
| GeneOntologyBiologicalProcess | positive regulation of smoothened signaling pathway | 8.55e-05 | 45 | 207 | 5 | GO:0045880 | |
| GeneOntologyBiologicalProcess | UDP-N-acetylgalactosamine transmembrane transport | 1.00e-04 | 2 | 207 | 2 | GO:0015789 | |
| GeneOntologyBiologicalProcess | UDP-glucuronic acid transmembrane transport | 1.00e-04 | 2 | 207 | 2 | GO:0015787 | |
| GeneOntologyBiologicalProcess | protein transmembrane transport | 1.16e-04 | 76 | 207 | 6 | GO:0071806 | |
| GeneOntologyBiologicalProcess | protein targeting to ER | 1.72e-04 | 52 | 207 | 5 | GO:0045047 | |
| GeneOntologyBiologicalProcess | establishment of protein localization to endoplasmic reticulum | 2.44e-04 | 56 | 207 | 5 | GO:0072599 | |
| GeneOntologyBiologicalProcess | protein insertion into ER membrane | 2.51e-04 | 31 | 207 | 4 | GO:0045048 | |
| GeneOntologyBiologicalProcess | cellular response to hydrostatic pressure | 2.99e-04 | 3 | 207 | 2 | GO:0071464 | |
| GeneOntologyBiologicalProcess | glycine betaine transport | 2.99e-04 | 3 | 207 | 2 | GO:0031460 | |
| GeneOntologyBiologicalProcess | positive regulation of acylglycerol transport | 2.99e-04 | 3 | 207 | 2 | GO:1901508 | |
| GeneOntologyBiologicalProcess | positive regulation of triglyceride transport | 2.99e-04 | 3 | 207 | 2 | GO:1905885 | |
| GeneOntologyBiologicalProcess | regulation of synaptic transmission, glutamatergic | 3.31e-04 | 92 | 207 | 6 | GO:0051966 | |
| GeneOntologyBiologicalProcess | synaptic transmission, glutamatergic | 3.79e-04 | 132 | 207 | 7 | GO:0035249 | |
| GeneOntologyBiologicalProcess | maintenance of protein localization in endoplasmic reticulum | 4.15e-04 | 15 | 207 | 3 | GO:0035437 | |
| MousePheno | motor neuron degeneration | 3.88e-06 | 38 | 158 | 6 | MP:0000938 | |
| Domain | ER_ret_rcpt | 1.34e-06 | 3 | 207 | 3 | IPR000133 | |
| Domain | ER_lumen_recept | 1.34e-06 | 3 | 207 | 3 | PF00810 | |
| Domain | ER_LUMEN_RECEPTOR_1 | 1.34e-06 | 3 | 207 | 3 | PS00951 | |
| Domain | ER_LUMEN_RECEPTOR_2 | 1.34e-06 | 3 | 207 | 3 | PS00952 | |
| Domain | 7tm_1 | OR11L1 OR5I1 TSHR OR2B11 GPR83 ADORA3 OR8B12 OR9A2 CCR10 OR2F2 HTR2A OR11H4 OR10Q1 OR5M11 ACKR4 OR6P1 OR6N1 OR52E2 LHCGR OR52A5 OR56A5 OR2Y1 LGR6 | 1.92e-06 | 677 | 207 | 23 | PF00001 |
| Domain | G_PROTEIN_RECEP_F1_1 | OR11L1 OR5I1 TSHR OR2B11 GPR83 ADORA3 OR8B12 OR9A2 CCR10 OR2F2 HTR2A OR11H4 OR10Q1 OR5M11 ACKR4 OR6P1 OR6N1 OR52E2 LHCGR OR52A5 OR56A5 OR2Y1 LGR6 | 2.34e-06 | 685 | 207 | 23 | PS00237 |
| Domain | G_PROTEIN_RECEP_F1_2 | OR11L1 OR5I1 TSHR OR2B11 GPR83 ADORA3 OR8B12 OR9A2 CCR10 OR2F2 HTR2A OR11H4 OR10Q1 OR5M11 ACKR4 OR6P1 OR6N1 OR52E2 LHCGR OR52A5 OR56A5 OR2Y1 LGR6 | 2.71e-06 | 691 | 207 | 23 | PS50262 |
| Domain | GPCR_Rhodpsn | OR11L1 OR5I1 TSHR OR2B11 GPR83 ADORA3 OR8B12 OR9A2 CCR10 OR2F2 HTR2A OR11H4 OR10Q1 OR5M11 ACKR4 OR6P1 OR6N1 OR52E2 LHCGR OR52A5 OR56A5 OR2Y1 LGR6 | 2.77e-06 | 692 | 207 | 23 | IPR000276 |
| Domain | GPCR_Rhodpsn_7TM | OR11L1 OR5I1 TSHR OR2B11 GPR83 ADORA3 OR8B12 OR9A2 CCR10 OR2F2 HTR2A OR11H4 OR10Q1 OR5M11 ACKR4 OR6P1 OR6N1 OR52E2 LHCGR OR52A5 OR56A5 OR2Y1 | 5.61e-06 | 670 | 207 | 22 | IPR017452 |
| Domain | Gphrmn_rcpt_fam | 2.62e-05 | 6 | 207 | 3 | IPR002131 | |
| Domain | Olfact_rcpt | OR11L1 OR5I1 OR2B11 OR8B12 OR9A2 OR2F2 OR11H4 OR10Q1 OR5M11 OR6P1 OR6N1 OR52E2 OR52A5 OR56A5 OR2Y1 | 3.43e-05 | 393 | 207 | 15 | IPR000725 |
| Domain | SecY_su_dom | 1.22e-04 | 2 | 207 | 2 | IPR023201 | |
| Domain | SECY_1 | 1.22e-04 | 2 | 207 | 2 | PS00755 | |
| Domain | SECY_2 | 1.22e-04 | 2 | 207 | 2 | PS00756 | |
| Domain | - | 1.22e-04 | 2 | 207 | 2 | 1.10.3370.10 | |
| Domain | Translocon_Sec61/SecY_plug_dom | 1.22e-04 | 2 | 207 | 2 | IPR019561 | |
| Domain | SecY_CS | 1.22e-04 | 2 | 207 | 2 | IPR030659 | |
| Domain | Plug_translocon | 1.22e-04 | 2 | 207 | 2 | PF10559 | |
| Domain | SecY | 1.22e-04 | 2 | 207 | 2 | PF00344 | |
| Domain | SecY/SEC61-alpha | 1.22e-04 | 2 | 207 | 2 | IPR002208 | |
| Domain | TRAM1 | 3.64e-04 | 3 | 207 | 2 | PF08390 | |
| Domain | DUF2075 | 3.64e-04 | 3 | 207 | 2 | PF09848 | |
| Domain | DUF2075 | 3.64e-04 | 3 | 207 | 2 | IPR018647 | |
| Domain | Translocation_assoc_membrane | 3.64e-04 | 3 | 207 | 2 | IPR016447 | |
| Domain | TRAM1 | 3.64e-04 | 3 | 207 | 2 | IPR013599 | |
| Domain | Channel_four-helix_dom | 4.18e-04 | 57 | 207 | 5 | IPR027359 | |
| Domain | - | 4.18e-04 | 57 | 207 | 5 | 1.20.120.350 | |
| Domain | VDCC_L_a1su | 7.23e-04 | 4 | 207 | 2 | IPR005446 | |
| Domain | - | 8.53e-04 | 222 | 207 | 9 | 1.25.10.10 | |
| Domain | ARM-like | 8.91e-04 | 270 | 207 | 10 | IPR011989 | |
| Domain | HEAT_REPEAT | 1.08e-03 | 70 | 207 | 5 | PS50077 | |
| Domain | AAA | 1.13e-03 | 144 | 207 | 7 | SM00382 | |
| Domain | AAA+_ATPase | 1.13e-03 | 144 | 207 | 7 | IPR003593 | |
| Domain | ABC_transporter_CS | 1.18e-03 | 42 | 207 | 4 | IPR017871 | |
| Domain | Myosin_S1_N | 1.20e-03 | 5 | 207 | 2 | IPR008989 | |
| Domain | Nuc_sug_transp | 1.20e-03 | 5 | 207 | 2 | PF04142 | |
| Domain | Cyt_P450_CYP7A1-type | 1.20e-03 | 5 | 207 | 2 | IPR024204 | |
| Domain | Nuc_sug_transpt | 1.20e-03 | 5 | 207 | 2 | IPR007271 | |
| Domain | P-loop_NTPase | MYO5A ABCA12 LRRK2 PEX1 UCK1 SMC5 MYO5C NOD1 ABCC8 ABCC2 DYNC1H1 NDST1 DYNC2H1 ABCC11 BTAF1 SLFN13 SLFN11 HYDIN ELP4 HELLS | 1.23e-03 | 848 | 207 | 20 | IPR027417 |
| Domain | ARM-type_fold | CAND1 IFT172 LRRK2 CLASP2 ELMO1 JUP ULK4 IPO8 HEATR5A BTAF1 STAG2 | 1.46e-03 | 339 | 207 | 11 | IPR016024 |
| Domain | - | ABCA12 LRRK2 PEX1 UCK1 SMC5 NOD1 ABCC8 ABCC2 DYNC1H1 NDST1 DYNC2H1 ABCC11 BTAF1 SLFN13 SLFN11 HYDIN ELP4 HELLS | 1.68e-03 | 746 | 207 | 18 | 3.40.50.300 |
| Domain | Ion_trans_dom | 1.70e-03 | 114 | 207 | 6 | IPR005821 | |
| Domain | Ion_trans | 1.70e-03 | 114 | 207 | 6 | PF00520 | |
| Domain | FN3 | 1.73e-03 | 199 | 207 | 8 | PS50853 | |
| Domain | Dilute_dom | 1.78e-03 | 6 | 207 | 2 | IPR002710 | |
| Domain | DIL | 1.78e-03 | 6 | 207 | 2 | PF01843 | |
| Domain | DILUTE | 1.78e-03 | 6 | 207 | 2 | PS51126 | |
| Domain | DIL | 1.78e-03 | 6 | 207 | 2 | SM01132 | |
| Domain | ABC_tran | 1.95e-03 | 48 | 207 | 4 | PF00005 | |
| Domain | HEAT | 1.95e-03 | 48 | 207 | 4 | PF02985 | |
| Domain | ABC_TRANSPORTER_2 | 1.95e-03 | 48 | 207 | 4 | PS50893 | |
| Domain | ABC_TRANSPORTER_1 | 2.10e-03 | 49 | 207 | 4 | PS00211 | |
| Domain | fn3 | 2.23e-03 | 162 | 207 | 7 | PF00041 | |
| Domain | ABC_transporter-like | 2.27e-03 | 50 | 207 | 4 | IPR003439 | |
| Domain | ABC_membrane | 2.29e-03 | 24 | 207 | 3 | PF00664 | |
| Domain | FN3_dom | 2.35e-03 | 209 | 207 | 8 | IPR003961 | |
| Domain | AlbA_2 | 2.47e-03 | 7 | 207 | 2 | PF04326 | |
| Domain | Schlafen | 2.47e-03 | 7 | 207 | 2 | IPR029684 | |
| Domain | Schlafen_AAA_dom | 2.47e-03 | 7 | 207 | 2 | IPR007421 | |
| Domain | Ca_chan_IQ | 2.47e-03 | 7 | 207 | 2 | SM01062 | |
| Domain | Ca_chan_IQ | 2.47e-03 | 7 | 207 | 2 | PF08763 | |
| Domain | Peptidase_C48_C | 2.47e-03 | 7 | 207 | 2 | IPR003653 | |
| Domain | Peptidase_C48 | 2.47e-03 | 7 | 207 | 2 | PF02902 | |
| Domain | VDCC_a1su_IQ | 2.47e-03 | 7 | 207 | 2 | IPR014873 | |
| Domain | GPHH | 2.47e-03 | 7 | 207 | 2 | PF16905 | |
| Domain | GPHH_dom | 2.47e-03 | 7 | 207 | 2 | IPR031649 | |
| Domain | ULP_PROTEASE | 2.47e-03 | 7 | 207 | 2 | PS50600 | |
| Pubmed | Different evolutionary processes shaped the mouse and human olfactory receptor gene families. | OR11L1 OR5I1 OR2B11 OR8B12 OR9A2 OR2F2 OR11H4 OR10Q1 OR5M11 OR6P1 OR6N1 OR52E2 OR52A5 OR56A5 OR2Y1 | 3.34e-09 | 340 | 212 | 15 | 11875048 |
| Pubmed | OR11L1 OR5I1 OR2B11 OR8B12 OR9A2 OR2F2 OR11H4 OR10Q1 OR5M11 OR6P1 OR6N1 OR52E2 OR52A5 OR56A5 OR2Y1 | 3.34e-09 | 340 | 212 | 15 | 11802173 | |
| Pubmed | OR11L1 OR5I1 OR2B11 OR8B12 OR9A2 OR2F2 OR11H4 OR10Q1 OR5M11 OR6P1 OR6N1 OR52E2 OR52A5 OR56A5 OR2Y1 | 3.76e-09 | 343 | 212 | 15 | 32295537 | |
| Pubmed | OR11L1 OR5I1 OR2B11 OR8B12 OR9A2 OR2F2 OR11H4 OR10Q1 OR5M11 OR6P1 OR6N1 OR52E2 OR52A5 OR56A5 OR2Y1 | 4.23e-09 | 346 | 212 | 15 | 14611657 | |
| Pubmed | ATP6AP1 EMC1 ZNF148 MYO5A ETFA CLASP2 MDH2 SLC38A2 TXNL1 MET JUP HSPA12A SACS CCDC138 SEC61A1 IPO8 DYNC2H1 SPG11 NFS1 SEC61A2 TBC1D31 TRAM1 NISCH TIMM50 TANC1 PDCL EPHA7 HELLS | 1.28e-07 | 1487 | 212 | 28 | 33957083 | |
| Pubmed | A molecular specificity code for the three mammalian KDEL receptors. | 2.23e-07 | 3 | 212 | 3 | 18086916 | |
| Pubmed | 2.23e-07 | 3 | 212 | 3 | 9118249 | ||
| Pubmed | Cell-type-specific differences in KDEL receptor clustering in mammalian cells. | 2.23e-07 | 3 | 212 | 3 | 32645101 | |
| Pubmed | 6.39e-07 | 12 | 212 | 4 | 9631292 | ||
| Pubmed | SHLD2/FAM35A co-operates with REV7 to coordinate DNA double-strand break repair pathway choice. | 4.19e-06 | 150 | 212 | 8 | 30154076 | |
| Pubmed | 4.41e-06 | 6 | 212 | 3 | 22232210 | ||
| Pubmed | ISG15 Connects Autophagy and IFN-γ-Dependent Control of Toxoplasma gondii Infection in Human Cells. | 6.50e-06 | 268 | 212 | 10 | 33024031 | |
| Pubmed | OR11L1 OR5I1 OR10J6P OR8B12 OR9A2 OR2F2 OR11H4 OR10Q1 OR5M11 OR6P1 OR6N1 OR52E2 OR52A5 OR2Y1 | 6.79e-06 | 541 | 212 | 14 | 14983052 | |
| Pubmed | ATP6AP1 EMC1 MYO5A CLASP2 HNRNPL FANCD2 ACSL4 HSPA12A PTPRD SUPT5H CCDC138 SEC61A1 UTRN TBC1D31 TIMM50 HSD17B12 TANC1 SLFN11 CNOT1 HELLS | 7.56e-06 | 1049 | 212 | 20 | 27880917 | |
| Pubmed | PLK2 CAND1 MYO5A IFT172 STAT6 STXBP1 PTPRD SATB1 SACS SUPT5H VPS35L ALAD PLEC UTRN DYNC1H1 NDST1 NRCAM REV3L NISCH SENP6 REPS2 ZMYM4 | 1.40e-05 | 1285 | 212 | 22 | 35914814 | |
| Pubmed | ATP6AP1 EMC1 PEX1 ACSL4 SLC38A2 JUP SLC35A2 VPS35L KDELR1 SPG11 LPCAT3 NISCH DCTN4 | 1.50e-05 | 504 | 212 | 13 | 34432599 | |
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | OR11L1 CAND1 ATP6AP1 LRRK2 GPRC5C MDH2 HNRNPL ACSL4 JUP HSPA12A STXBP1 PKD2 ALDH3B1 UTRN DYNC1H1 DPYS DYNC2H1 AOX1 ABCC11 | 1.68e-05 | 1016 | 212 | 19 | 19056867 |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | CAND1 EMC1 MYO5A ETFA MDH2 HNRNPL MYO5C JUP SACS SUPT5H PLEC UTRN DYNC1H1 BTAF1 TIMM50 USP39 CNOT1 STAG2 HELLS | 1.87e-05 | 1024 | 212 | 19 | 24711643 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | CAND1 EMC1 ETFA CLASP2 MDH2 USP19 HNRNPL FANCD2 SLC38A2 JUP ANAPC1 SUPT5H SEC61A1 DYNC1H1 IPO8 DYNC2H1 CARS1 TIMM50 HSD17B12 USP39 CNOT1 STAG2 HELLS | 2.24e-05 | 1425 | 212 | 23 | 30948266 |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | ZNF148 FSIP2 SATB1 KDELR1 BTAF1 TBL1XR1 ARID3B ZFP1 SENP6 USP39 STAG2 ZMYM4 SENP7 HELLS | 2.48e-05 | 608 | 212 | 14 | 36089195 |
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | EMC1 SSR3 SUCLG2 HNRNPL FANCD2 STXBP1 KDELR1 SEC61A1 DYNC1H1 UBA2 CPS1 TBL1XR1 TIMM50 DCTN4 CNOT1 | 3.11e-05 | 704 | 212 | 15 | 29955894 |
| Pubmed | PDL-1/PDL-2 blockade in mice dendritic cells by RNAi techniques to induce antitumor immunity. | 3.70e-05 | 2 | 212 | 2 | 26599163 | |
| Pubmed | Over-Expression of Immunosuppressive Molecules, PD-L1 and PD-L2, in Ulcerative Colitis Patients. | 3.70e-05 | 2 | 212 | 2 | 30864556 | |
| Pubmed | 3.70e-05 | 2 | 212 | 2 | 30357491 | ||
| Pubmed | Lack of PD-L1 expression by iNKT cells improves the course of influenza A infection. | 3.70e-05 | 2 | 212 | 2 | 23555047 | |
| Pubmed | Genetic Basis for PD-L1 Expression in Squamous Cell Carcinomas of the Cervix and Vulva. | 3.70e-05 | 2 | 212 | 2 | 26913631 | |
| Pubmed | 3.70e-05 | 2 | 212 | 2 | 19741598 | ||
| Pubmed | Increased expression of PD-L1 and PD-L2 in dermal fibroblasts from alopecia areata mice. | 3.70e-05 | 2 | 212 | 2 | 28777458 | |
| Pubmed | 3.70e-05 | 2 | 212 | 2 | 16517716 | ||
| Pubmed | Prognostic significance of PD-L1 and PD-L2 in breast cancer. | 3.70e-05 | 2 | 212 | 2 | 26541326 | |
| Pubmed | 3.70e-05 | 2 | 212 | 2 | 30815803 | ||
| Pubmed | Absence of ion channels CACN1AS and SCN4A mutations in thyrotoxic hypokalemic periodic paralysis. | 3.70e-05 | 2 | 212 | 2 | 15072700 | |
| Pubmed | 3.70e-05 | 2 | 212 | 2 | 33693450 | ||
| Pubmed | 3.70e-05 | 2 | 212 | 2 | 18378285 | ||
| Pubmed | Mutation analysis of CACNA1S and SCN4A in patients with hypokalemic periodic paralysis. | 3.70e-05 | 2 | 212 | 2 | 26252573 | |
| Pubmed | PD-L1 and PD-L2 have distinct roles in regulating host immunity to cutaneous leishmaniasis. | 3.70e-05 | 2 | 212 | 2 | 16358363 | |
| Pubmed | 3.70e-05 | 2 | 212 | 2 | 32730911 | ||
| Pubmed | Genetic analysis of the cytoplasmic dynein subunit families. | 3.70e-05 | 2 | 212 | 2 | 16440056 | |
| Pubmed | c-Met and PD-L1 on Circulating Exosomes as Diagnostic and Prognostic Markers for Pancreatic Cancer. | 3.70e-05 | 2 | 212 | 2 | 31284422 | |
| Pubmed | Voltage sensor charge loss accounts for most cases of hypokalemic periodic paralysis. | 3.70e-05 | 2 | 212 | 2 | 19118277 | |
| Pubmed | 3.70e-05 | 2 | 212 | 2 | 31825827 | ||
| Pubmed | 3.70e-05 | 2 | 212 | 2 | 29112015 | ||
| Pubmed | 3.70e-05 | 2 | 212 | 2 | 17924994 | ||
| Pubmed | Co-inhibitory role of T-cell-associated B7-H1 and B7-DC in the T-cell immune response. | 3.70e-05 | 2 | 212 | 2 | 16236366 | |
| Pubmed | 3.70e-05 | 2 | 212 | 2 | 26329973 | ||
| Pubmed | 3.70e-05 | 2 | 212 | 2 | 27268263 | ||
| Pubmed | 3.70e-05 | 2 | 212 | 2 | 27447090 | ||
| Pubmed | 3.70e-05 | 2 | 212 | 2 | 26051731 | ||
| Pubmed | Expression cloning of an oxysterol 7alpha-hydroxylase selective for 24-hydroxycholesterol. | 3.70e-05 | 2 | 212 | 2 | 10748047 | |
| Pubmed | 3.70e-05 | 2 | 212 | 2 | 34125179 | ||
| Pubmed | 3.70e-05 | 2 | 212 | 2 | 34768993 | ||
| Pubmed | Profiling phagosome proteins identifies PD-L1 as a fungal-binding receptor. | 3.70e-05 | 2 | 212 | 2 | 38839956 | |
| Pubmed | 3.70e-05 | 2 | 212 | 2 | 20722638 | ||
| Pubmed | 3.70e-05 | 2 | 212 | 2 | 34793833 | ||
| Pubmed | 3.70e-05 | 2 | 212 | 2 | 37768345 | ||
| Pubmed | 3.70e-05 | 2 | 212 | 2 | 38073444 | ||
| Pubmed | 3.70e-05 | 2 | 212 | 2 | 30683910 | ||
| Pubmed | Variations in testosterone pathway genes and susceptibility to testicular cancer in Norwegian men. | 3.70e-05 | 2 | 212 | 2 | 22882535 | |
| Pubmed | Blockade of B7-H1 or B7-DC induces an anti-tumor effect in a mouse pancreatic cancer model. | 3.70e-05 | 2 | 212 | 2 | 19724910 | |
| Pubmed | 3.70e-05 | 2 | 212 | 2 | 12538684 | ||
| Pubmed | 3.70e-05 | 2 | 212 | 2 | 32264742 | ||
| Pubmed | PD-L1 and PD-L2 Mutations in Pediatric Hodgkin Lymphoma: Do They Have Any Prognostic Significance? | 3.70e-05 | 2 | 212 | 2 | 32401663 | |
| Pubmed | 3.70e-05 | 2 | 212 | 2 | 22204817 | ||
| Pubmed | 3.70e-05 | 2 | 212 | 2 | 8616892 | ||
| Pubmed | Clinical significance of PD-L1 and PD-L2 copy number gains in non-small-cell lung cancer. | 3.70e-05 | 2 | 212 | 2 | 27050074 | |
| Pubmed | PD-L1/PD-L2-expressing B-1 cells inhibit alloreactive T cells in mice. | 3.70e-05 | 2 | 212 | 2 | 28570665 | |
| Pubmed | 3.70e-05 | 2 | 212 | 2 | 32579541 | ||
| Pubmed | 3.70e-05 | 2 | 212 | 2 | 31931443 | ||
| Pubmed | 3.70e-05 | 2 | 212 | 2 | 36656207 | ||
| Pubmed | 3.70e-05 | 2 | 212 | 2 | 23188068 | ||
| Pubmed | 3.70e-05 | 2 | 212 | 2 | 25502651 | ||
| Pubmed | Interferon Receptor Signaling Pathways Regulating PD-L1 and PD-L2 Expression. | 3.70e-05 | 2 | 212 | 2 | 28494868 | |
| Pubmed | 3.70e-05 | 2 | 212 | 2 | 18162522 | ||
| Pubmed | PD-L1 and PD-L2 Genetic Alterations Define Classical Hodgkin Lymphoma and Predict Outcome. | 3.70e-05 | 2 | 212 | 2 | 27069084 | |
| Pubmed | 3.70e-05 | 2 | 212 | 2 | 11312274 | ||
| Pubmed | 3.70e-05 | 2 | 212 | 2 | 35759432 | ||
| Pubmed | PD-L1 and PD-L2 Expression in Cervical Cancer: Regulation and Biomarker Potential. | 3.70e-05 | 2 | 212 | 2 | 33424844 | |
| Pubmed | Detailed haplotype-tagging study of germline variation of MUC19 in inflammatory bowel disease. | 3.70e-05 | 2 | 212 | 2 | 19714762 | |
| Pubmed | Identification of the Isoform-specific Interactions between the Tail and the Head of Class V Myosin. | 3.70e-05 | 2 | 212 | 2 | 26912658 | |
| Pubmed | 3.70e-05 | 2 | 212 | 2 | 22067141 | ||
| Pubmed | 3.70e-05 | 2 | 212 | 2 | 21220347 | ||
| Pubmed | 3.70e-05 | 2 | 212 | 2 | 37146414 | ||
| Pubmed | 3.70e-05 | 2 | 212 | 2 | 33581199 | ||
| Pubmed | Do PD-1 and PD-L2 expressions have prognostic impact in hematologic malignancies? | 3.70e-05 | 2 | 212 | 2 | 30761875 | |
| Pubmed | 3.70e-05 | 2 | 212 | 2 | 27911948 | ||
| Pubmed | Programmed death ligand-1 expression and its prognostic role in esophageal squamous cell carcinoma. | 3.70e-05 | 2 | 212 | 2 | 27729745 | |
| Pubmed | 3.70e-05 | 2 | 212 | 2 | 26464193 | ||
| Pubmed | 3.70e-05 | 2 | 212 | 2 | 22309849 | ||
| Pubmed | 3.70e-05 | 2 | 212 | 2 | 32494600 | ||
| Pubmed | Programmed death 1 ligand (PD-L) 1 and PD-L2 limit autoimmune kidney disease: distinct roles. | 3.70e-05 | 2 | 212 | 2 | 18025191 | |
| Pubmed | 3.70e-05 | 2 | 212 | 2 | 2293030 | ||
| Pubmed | 3.70e-05 | 2 | 212 | 2 | 21307196 | ||
| Pubmed | Soluble PD-1 ligands regulate T-cell function in Waldenstrom macroglobulinemia. | 3.70e-05 | 2 | 212 | 2 | 30104397 | |
| Pubmed | 3.70e-05 | 2 | 212 | 2 | 28561677 | ||
| Pubmed | 3.70e-05 | 2 | 212 | 2 | 30659749 | ||
| Pubmed | PD-1 ligands expressed on myeloid-derived APC in the CNS regulate T-cell responses in EAE. | 3.70e-05 | 2 | 212 | 2 | 18825752 | |
| Pubmed | Programmed death-ligand 1, 2 expressions are decreased in the psoriatic epidermis. | 3.70e-05 | 2 | 212 | 2 | 26133691 | |
| Pubmed | 3.70e-05 | 2 | 212 | 2 | 32089543 | ||
| Pubmed | Detrimental contribution of the immuno-inhibitor B7-H1 to rabies virus encephalitis. | 3.70e-05 | 2 | 212 | 2 | 18490751 | |
| Pubmed | 3.70e-05 | 2 | 212 | 2 | 32248797 | ||
| Interaction | OPALIN interactions | GPRC5C FANCD2 PTPRD KDELR1 ABCC2 KDELR2 KDELR3 IPO8 FASTKD1 BTAF1 SEC61A2 ATP2C1 | 8.13e-07 | 209 | 192 | 12 | int:OPALIN |
| Interaction | VIPR1 interactions | HNRNPL FANCD2 KDELR1 KDELR2 KDELR3 FASTKD1 BTAF1 SLC7A6 SEC61A2 LPCAT3 HSD17B12 | 4.54e-06 | 205 | 192 | 11 | int:VIPR1 |
| Interaction | GPR45 interactions | PEX1 GPRC5C FANCD2 HSPA12A KDELR1 KDELR3 IPO8 FASTKD1 SPG11 BTAF1 SLC7A6 ATP2C1 ZMYM4 | 6.44e-06 | 300 | 192 | 13 | int:GPR45 |
| Interaction | GPR182 interactions | CAND1 GPRC5C FANCD2 ACSL4 CCDC138 ALDH3B1 KDELR3 IPO8 FASTKD1 SPG11 BTAF1 SLC7A6 SEC61A2 ATP2C1 LPCAT3 HELLS | 7.93e-06 | 455 | 192 | 16 | int:GPR182 |
| Interaction | CRYL1 interactions | 1.51e-05 | 56 | 192 | 6 | int:CRYL1 | |
| Interaction | CCL19 interactions | 2.77e-05 | 19 | 192 | 4 | int:CCL19 | |
| GeneFamily | Solute carriers | SLCO1B3 SLC35D1 SLC38A2 SLC35F3 SLC35A2 SLC35A5 SLC35D2 SLC7A6 SLCO1B7 SLC6A2 SLC7A8 SLC32A1 SLC25A52 | 3.93e-05 | 395 | 156 | 13 | 752 |
| GeneFamily | ATP binding cassette subfamily C | 1.69e-04 | 13 | 156 | 3 | 807 | |
| GeneFamily | Glycoprotein hormone receptors | 2.21e-04 | 3 | 156 | 2 | 199 | |
| GeneFamily | Myosins, class V | 2.21e-04 | 3 | 156 | 2 | 1100 | |
| GeneFamily | Fibronectin type III domain containing | 4.82e-04 | 160 | 156 | 7 | 555 | |
| GeneFamily | Schlafen family | 1.51e-03 | 7 | 156 | 2 | 1110 | |
| GeneFamily | SUMO specific peptidases | 1.51e-03 | 7 | 156 | 2 | 984 | |
| GeneFamily | TLC domain containing | 3.18e-03 | 10 | 156 | 2 | 1374 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-4|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 1.45e-09 | 184 | 212 | 11 | 67164bb6bcae7322cb89b585c7aa10bce35b0ecd | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ABCA12 LAMA1 FREM1 PTPRD CACNA1F FAT4 NRCAM CPS1 HYDIN EPHA7 | 2.04e-08 | 184 | 212 | 10 | 2cbed6462fea2622871bb7e49b0df3d984239281 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ABCA12 LAMA1 FREM1 PTPRD CACNA1F FAT4 NRCAM CPS1 HYDIN EPHA7 | 2.04e-08 | 184 | 212 | 10 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ABCA12 LAMA1 FREM1 PTPRD CACNA1F FAT4 NRCAM CPS1 HYDIN EPHA7 | 2.04e-08 | 184 | 212 | 10 | 2b19a8c5f823e00812908b23e66bb4e563278aff |
| ToppCell | facs-Bladder-nan-3m|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | SSR3 PKD2 UTRN DYNC1H1 KDELR2 KDELR3 REV3L TRAM1 NISCH TANC1 | 3.72e-08 | 196 | 212 | 10 | 44f5b1b474399c9316729155f2ea95a82ca66e30 |
| ToppCell | facs-Bladder-nan-3m-Epithelial|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | SSR3 PKD2 UTRN DYNC1H1 KDELR2 KDELR3 REV3L TRAM1 NISCH TANC1 | 3.72e-08 | 196 | 212 | 10 | c0e90d964baa2eb4fbd18a52379ccec5d3bf59a8 |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 3.87e-07 | 193 | 212 | 9 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.01e-06 | 175 | 212 | 8 | fd8b5b756f3df4a04938785f3d9edbb6f1cd20f6 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.01e-06 | 175 | 212 | 8 | 36c140540497bbe1c5f08fac2d94f08cac18fabb | |
| ToppCell | COVID-19-kidney-PCT-S1|kidney / Disease (COVID-19 only), tissue and cell type | 2.92e-06 | 184 | 212 | 8 | 51ed1ebfdef45149541917c66cbacad87072e51f | |
| ToppCell | droplet-Marrow-nan-3m-Lymphocytic-late_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.92e-06 | 184 | 212 | 8 | 42cadfdb5d29a50bd7e901ddd14d42b39e8474f0 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.17e-06 | 186 | 212 | 8 | f28d72b47624b69a580b4429e2be560a26898591 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.86e-06 | 191 | 212 | 8 | 1cb02007adb344f17ef73d58890f91298c7cf5a1 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_B-Plasma_cell-B_c05-MZB1-XBP1|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.86e-06 | 191 | 212 | 8 | 208cd307826b5af89f8f10c0c915f90f80a25c6c | |
| ToppCell | COVID-19_Moderate-Plasmablast|COVID-19_Moderate / disease group, cell group and cell class | 4.01e-06 | 192 | 212 | 8 | 25c6c7a244190f82c7feab874bdec12490b7de4d | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_proliferating-epi_proliferating3_(5)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 4.01e-06 | 192 | 212 | 8 | d3634574b2e8d2ded6446969361b70761b331aea | |
| ToppCell | COVID-19_Severe-Plasmablast|COVID-19_Severe / disease group, cell group and cell class | 4.16e-06 | 193 | 212 | 8 | 8074bcede261b85f9ae03ee372bd6d4b40384537 | |
| ToppCell | severe-Plasmablast|World / disease stage, cell group and cell class | 4.33e-06 | 194 | 212 | 8 | 49e8f90db571a89b8a26aef31fcacd66429fed11 | |
| ToppCell | COVID-19_Convalescent-Lymphoid_P|COVID-19_Convalescent / Disease group, lineage and cell class | 4.49e-06 | 195 | 212 | 8 | 4fff177aa4617060b594e637885cd0c91e7d6609 | |
| ToppCell | COVID-19_Convalescent-Lymphoid_P-Plasmablast|COVID-19_Convalescent / Disease group, lineage and cell class | 4.49e-06 | 195 | 212 | 8 | b4cfc31e4f7e899c6b2578b1ea4fbf609b7ae914 | |
| ToppCell | severe-Plasmablast|severe / disease stage, cell group and cell class | 4.49e-06 | 195 | 212 | 8 | e11616ad568e50e4c720b50b0c071f484c31d16b | |
| ToppCell | Smart-seq2-bone_marrow_(Smart-seq2)-lymphocytic-B_lymphocytic-plasma_cell|bone_marrow_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.49e-06 | 195 | 212 | 8 | fb3d6a3b10aedc7fdd9789b2c47b4e80fa8e411f | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.84e-06 | 197 | 212 | 8 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | COVID-19-COVID-19_Convalescent-Lymphocyte-B-Plasmablast|COVID-19_Convalescent / Disease, condition lineage and cell class | 5.22e-06 | 199 | 212 | 8 | 7bd4a07c4d0843921a99d5c6df6eb55e62f1ba0e | |
| ToppCell | Thalamus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Thalamus / BrainAtlas - Mouse McCarroll V32 | 7.12e-06 | 148 | 212 | 7 | afebb64365c94b9476494bffe7c364677f19c8cf | |
| ToppCell | Thalamus-Neuronal-Inhibitory|Thalamus / BrainAtlas - Mouse McCarroll V32 | 7.12e-06 | 148 | 212 | 7 | 5f82e5ecacfd223020b8ee975c17d68c1fe6db38 | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Epithelial-Hepatocyte_(Pericentral)|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.18e-05 | 160 | 212 | 7 | c42bcc6c7d113f0db43febb088b75ca4ac7cb7a3 | |
| ToppCell | Globus_pallidus-Neuronal-Inhibitory-iN2(Gad1Gad2)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.35e-05 | 64 | 212 | 5 | 0f13fbeda23ab9df3488cfae98cb6cd7a3c1b332 | |
| ToppCell | facs-Trachea-3m-Hematologic-myeloid-granulocyte-granulocyte_l26|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.45e-05 | 165 | 212 | 7 | 23955e3373660f827518e723ac62fba99753f375 | |
| ToppCell | facs-Marrow-KLS-3m-Hematologic-Unknown_Progenitor|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.69e-05 | 169 | 212 | 7 | b798b91567d2f49082e2d8a337169f241c8d2080 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.69e-05 | 169 | 212 | 7 | 14aadc2d1bf66eb47dac33b4d61ddb3c942caa4f | |
| ToppCell | BL-critical-LOC-Epithelial-Ionocyte|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.75e-05 | 170 | 212 | 7 | b465df2dac6b4e98b4ede6ad0c6347656757885c | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.82e-05 | 171 | 212 | 7 | 913bae728b5e653771a27c79a309eb023699f1d0 | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.82e-05 | 171 | 212 | 7 | f28b2336057e353b96a6ff4581ec9fd0ca0789d9 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Mesenchymal-brain_pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.96e-05 | 173 | 212 | 7 | 2415b6ff49f334da570577d4e93484d024a3dbd5 | |
| ToppCell | facs-Marrow-T_cells-18m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.96e-05 | 173 | 212 | 7 | e0cf99ddbe6e9eab05d7bf89e9aa124850c6a807 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Mesenchymal-Pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.96e-05 | 173 | 212 | 7 | 2acd0693a2dfe04e3c1b2125ea63efe92d13150b | |
| ToppCell | normal_Lymph_Node-Myeloid_cells-pDCs|Myeloid_cells / Location, Cell class and cell subclass | 2.04e-05 | 174 | 212 | 7 | 2274648b80dd74f3c948a779bba3391095964c34 | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN2(Gad1Gad2)-Phlda1-Inhibitory_Gad1Gad2_Htr3a.Phlda1_(Interneuron,__(candidate_CGE-derived_3))-|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 2.09e-05 | 70 | 212 | 5 | 0f1dba07a2cd974a25239ae1728cfb007a37954c | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN2(Gad1Gad2)-Phlda1|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 2.09e-05 | 70 | 212 | 5 | c579fd093d30a5ee56f7cf1039120d00a6369649 | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN2(Gad1Gad2)-Phlda1-Inhibitory_Gad1Gad2_Htr3a.Phlda1_(Interneuron,__(candidate_CGE-derived_3))|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 2.09e-05 | 70 | 212 | 5 | 511ca39208a8a0efd24cca47270083d5024e6972 | |
| ToppCell | facs-Marrow-T_cells-18m-Hematologic-hematopoietic_stem_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.11e-05 | 175 | 212 | 7 | 4be01bf30331162f1998216fb2871a4e626dc440 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Mucinous_Colon_Adenocarcinoma-10|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 2.44e-05 | 179 | 212 | 7 | cc079ba015326dccde955c5eafa3e4a2e40de192 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.62e-05 | 181 | 212 | 7 | 9d782ba5cf5a172cb4f447763fc50e5b13ef7dd9 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_B_plasma-Plasma_cells|lymph-node_spleen / Manually curated celltypes from each tissue | 2.81e-05 | 183 | 212 | 7 | a6866951866373a1029e04818f4a4a31278c409d | |
| ToppCell | COVID-19-kidney-PCT-S1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.81e-05 | 183 | 212 | 7 | 6878d14026c3df6aa12e45dfad94b32fa9d9b0b7 | |
| ToppCell | 10x5'-GI_large-bowel-Lymphocytic_B_plasma-Plasma_cells|GI_large-bowel / Manually curated celltypes from each tissue | 3.02e-05 | 185 | 212 | 7 | 2cad994207c4afc9d70f4c2d243ffbbcdbba693e | |
| ToppCell | 10x5'-GI_large-bowel-Lymphocytic_B_plasma|GI_large-bowel / Manually curated celltypes from each tissue | 3.02e-05 | 185 | 212 | 7 | 989583c487d8c121e3731faf68f863ba43a582e6 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L4_RORB_CCDC168|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.02e-05 | 185 | 212 | 7 | 5a0340c25196453f19e424d346efbf66d2c53ac3 | |
| ToppCell | mild-Lymphocytic-Plasmablast|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 3.12e-05 | 186 | 212 | 7 | 060510c21b1e0889b7a6eeb15821b9e2f03a0f99 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Epithelial-luminal_epithelial_cell_of_mammary_gland|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.12e-05 | 186 | 212 | 7 | 02fbb02c495e7d64c4ab50e42e5197782f2c0816 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.12e-05 | 186 | 212 | 7 | f0c8de4f6ae9047b9108a47a2af8c5f42bc103b0 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.34e-05 | 188 | 212 | 7 | af740fa78542438fdff627ea1f74f4eee43316be | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.34e-05 | 188 | 212 | 7 | 63a4b25a0a6e05f80f1a6dd91b817f3cf49e6b68 | |
| ToppCell | normal-na-Lymphocytic_B-B_plasma|normal / PBMC cell types (v2) per disease, treatment status, and sex | 3.46e-05 | 189 | 212 | 7 | 659deb617a560bcde67c75f477d30ce85aaec3c6 | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_B-B_plasma-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.46e-05 | 189 | 212 | 7 | 59e6fec454de621119571d4a8ec48be3bf02a32e | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.46e-05 | 189 | 212 | 7 | 3b48b0d220cc24d5170713d61fa91f5bb6c21841 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.46e-05 | 189 | 212 | 7 | 975c0f079903ae36b0ffa54e86294d42ec7697de | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.46e-05 | 189 | 212 | 7 | 7eb8f5a951e80f1cfac4d7c9eb169f4eb100c917 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.46e-05 | 189 | 212 | 7 | 28b502611829e4a24caff2562545c7db97686099 | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_B-B_plasma|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.46e-05 | 189 | 212 | 7 | 43f25fb7257eab05df921ffcd5a6e49c78a03e3a | |
| ToppCell | normal-na-Lymphocytic_B-B_plasma-female|normal / PBMC cell types (v2) per disease, treatment status, and sex | 3.46e-05 | 189 | 212 | 7 | 67f9a9861d2dcc128b7a69432c6b31da185e2249 | |
| ToppCell | tumor_Lymph_Node_/_Brain-B_lymphocytes-MALT_B_cells|B_lymphocytes / Location, Cell class and cell subclass | 3.58e-05 | 190 | 212 | 7 | ce70336679a2b713836e7497e6dc48aac612b018 | |
| ToppCell | 368C-Lymphocytic-NK_cells-NK_cell_D3|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.70e-05 | 191 | 212 | 7 | d7920f4a602b50d0ef064eb47001e71939695ed2 | |
| ToppCell | severe-Lymphocytic-Plasmablast|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 3.70e-05 | 191 | 212 | 7 | 73660d762c9d451980c21adc426db6670bcaf37f | |
| ToppCell | PBMC-Convalescent-Lymphocyte-B-Plasmablast-Plasmablast-Plasmablast|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.70e-05 | 191 | 212 | 7 | dd1d38a531a272a746c16807688013d29cab823a | |
| ToppCell | remission-Plasmablast|remission / disease stage, cell group and cell class | 3.82e-05 | 192 | 212 | 7 | 4bcf22061905177ad8625b87be2fbca9bff03ec6 | |
| ToppCell | Ciliated-cil-3|World / Class top | 3.82e-05 | 192 | 212 | 7 | 4989ebb8812b8af1870599acd932849122c05a29 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-ciliated_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.82e-05 | 192 | 212 | 7 | 03acd4a26b986e34eee608747347791122f1aa52 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-ciliated_cell-Epi-Ciliated|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.82e-05 | 192 | 212 | 7 | 31c6046589e2fbb0486fd044c5b128099d37872f | |
| ToppCell | PBMC-Convalescent-Lymphocyte-B-Plasmablast-Plasmablast-|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.95e-05 | 193 | 212 | 7 | 902dea0bf6c2997d8b877ae01113460e511a364a | |
| ToppCell | PBMC-Convalescent-Lymphocyte-B-Plasmablast|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.95e-05 | 193 | 212 | 7 | 239f2ac64f63d4d65997ba83b932a1fab1909efb | |
| ToppCell | PBMC-Convalescent-Lymphocyte-B-Plasmablast-Plasmablast|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.95e-05 | 193 | 212 | 7 | 2790b245d6052063c207087b91fb9375a0e8055d | |
| ToppCell | remission-Plasmablast|World / disease stage, cell group and cell class | 3.95e-05 | 193 | 212 | 7 | d62617c72863642f2222f7ed28bc6b90ee09b4e0 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-B-Plasmablast-Plasmablast|Convalescent / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.95e-05 | 193 | 212 | 7 | 94daa8a5d23558998fe3bff585344e22ce679f2d | |
| ToppCell | PBMC-Convalescent-Lymphocyte-B-Plasmablast|Convalescent / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.95e-05 | 193 | 212 | 7 | 33dad901e0597f0057edc2bfbd64fd81f298b94e | |
| ToppCell | B_cell_maturation-plasma|B_cell_maturation / Lineage and Cell class | 3.95e-05 | 193 | 212 | 7 | 5415f7e54bc40aec3dbe27fd97f6e9be6db08a48 | |
| ToppCell | (07)_Brush|World / shred by cell type and Timepoint | 3.95e-05 | 193 | 212 | 7 | 9af9d22a130ff97a9c37142a65e841b056d08640 | |
| ToppCell | Smart-seq2-bone_marrow_(Smart-seq2)-lymphocytic-B_lymphocytic|bone_marrow_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.08e-05 | 194 | 212 | 7 | 3c30f86806f6a0f43e6103ad7009f4c6a90e011c | |
| ToppCell | normal_Lymph_Node-B_lymphocytes-MALT_B_cells|B_lymphocytes / Location, Cell class and cell subclass | 4.08e-05 | 194 | 212 | 7 | 1ca034f25a8fce503fb67654d7fa2a8ec71976be | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.08e-05 | 194 | 212 | 7 | 4a2c127c90d1fefe604fcb9e796577d21b489dd6 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.22e-05 | 195 | 212 | 7 | d3755929ebbbf5e3afde44281e9056ddb614a291 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.22e-05 | 195 | 212 | 7 | 19853c654ac64b3ae3bc99841c6cb29c8aaba85c | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.22e-05 | 195 | 212 | 7 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.22e-05 | 195 | 212 | 7 | 787e95fb59c40bba784544b662fac37606ae1427 | |
| ToppCell | Mild/Remission-Plasmablast|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 4.22e-05 | 195 | 212 | 7 | 52bdd609253613b7db75dccbc1c01c05e8d73f79 | |
| ToppCell | Severe-Plasmablast|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 4.36e-05 | 196 | 212 | 7 | ee991f1d9936c656f4fbc2e0cec9e0166a34bc5b | |
| ToppCell | tumor_Lung-B_lymphocytes-MALT_B_cells|B_lymphocytes / Location, Cell class and cell subclass | 4.36e-05 | 196 | 212 | 7 | 1f63dba9d226e4a42d9bee7258580a1e547c0e92 | |
| ToppCell | Mild/Remission-Plasmablast|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 4.36e-05 | 196 | 212 | 7 | dcf0a804a79a05454658498d1f87320c7e079219 | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_2-Differentiating_AT2|Control_saline / Treatment groups by lineage, cell group, cell type | 4.50e-05 | 197 | 212 | 7 | 44a59dfb889577b3160a5b13ada1276771a00241 | |
| ToppCell | Severe|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 4.50e-05 | 197 | 212 | 7 | df3f58b58f82c42c65b0a09c054b669b34502037 | |
| ToppCell | (1)_B_cell-(101)_plasma|(1)_B_cell / immune cells in Peripheral Blood (logTPM normalization) | 4.50e-05 | 197 | 212 | 7 | c86fcd779f30074bdf0b23d763fee5b7e4a6e4f5 | |
| ToppCell | Severe-Plasmablast|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 4.50e-05 | 197 | 212 | 7 | 1089aa7991812378668d0f3d57f8000e6245a713 | |
| ToppCell | B_cells-Plasma_cells_and_plasmablasts|B_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 4.50e-05 | 197 | 212 | 7 | 3b1c574b3d119b63967bb1306f0353ecc4c522f3 | |
| ToppCell | (1)_B_cell-(10)_B_cell-(101)_plasma|(10)_B_cell / immune cells in Peripheral Blood (logTPM normalization) | 4.50e-05 | 197 | 212 | 7 | c7af5510e2dd69b6a044244b22e62b82f474fdbd | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 4.50e-05 | 197 | 212 | 7 | 11a4c417f035e554431a8f03be13b5eefa3530c0 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 4.64e-05 | 198 | 212 | 7 | b598ab958e31f1e98bd06dc0097b58ac3a3f90a3 | |
| ToppCell | LPS_only-Epithelial_airway-airway_epithelial-Ciliated|LPS_only / Treatment groups by lineage, cell group, cell type | 4.64e-05 | 198 | 212 | 7 | 6d90b541fde357fbb40f8f7d4e8628a48b679718 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-CR|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.77e-05 | 83 | 212 | 5 | 1ab68323518adc7fd0a459b41fad12d60f97eb5c | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-CR-CR_Lhx5|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.77e-05 | 83 | 212 | 5 | 75b27d91a4473286f4b40027e96ac5246f5abe5b | |
| Disease | bilirubin metabolic disorder (implicated_via_orthology) | 3.27e-06 | 5 | 205 | 3 | DOID:2741 (implicated_via_orthology) | |
| Disease | hexadecenedioate (C16:1-DC) measurement | 2.69e-05 | 9 | 205 | 3 | EFO_0800562 | |
| Disease | X-21467 measurement | 2.69e-05 | 9 | 205 | 3 | EFO_0020007 | |
| Disease | HYPOKALEMIC PERIODIC PARALYSIS, TYPE 1 | 4.80e-05 | 2 | 205 | 2 | 170400 | |
| Disease | Hypokalemic periodic paralysis, type 1 | 4.80e-05 | 2 | 205 | 2 | cv:C3714580 | |
| Disease | Hypokalemic periodic paralysis | 4.80e-05 | 2 | 205 | 2 | cv:C0238358 | |
| Disease | glycochenodeoxycholate glucuronide (1) measurement | 8.98e-05 | 13 | 205 | 3 | EFO_0800474 | |
| Disease | Duchenne muscular dystrophy (implicated_via_orthology) | 1.12e-04 | 36 | 205 | 4 | DOID:11723 (implicated_via_orthology) | |
| Disease | Colorectal Carcinoma | STARD8 ABCA12 LAMA1 SLCO1B3 ACSL4 ADORA3 PTPRD SACS ABCC8 ABCC2 IQUB NRCAM LGR6 ZMYM4 EPHA7 | 1.27e-04 | 702 | 205 | 15 | C0009402 |
| Disease | Hypokalemic periodic paralysis type 1 | 1.43e-04 | 3 | 205 | 2 | C3714580 | |
| Disease | Olmsted syndrome | 1.43e-04 | 3 | 205 | 2 | C2609071 | |
| Disease | Colorectal Neoplasms | 1.48e-04 | 277 | 205 | 9 | C0009404 | |
| Disease | invasive ductal carcinoma (is_marker_for) | 1.70e-04 | 40 | 205 | 4 | DOID:3008 (is_marker_for) | |
| Disease | glutarylcarnitine (C5-DC) measurement | 2.09e-04 | 17 | 205 | 3 | EFO_0800030 | |
| Disease | X-21441 measurement | 2.09e-04 | 17 | 205 | 3 | EFO_0800814 | |
| Disease | Timothy syndrome (implicated_via_orthology) | 2.86e-04 | 4 | 205 | 2 | DOID:0060173 (implicated_via_orthology) | |
| Disease | congenital stationary night blindness (is_implicated_in) | 2.86e-04 | 4 | 205 | 2 | DOID:0050534 (is_implicated_in) | |
| Disease | Hypokalemic periodic paralysis | 2.86e-04 | 4 | 205 | 2 | C0238358 | |
| Disease | Thymus Neoplasms | 2.86e-04 | 4 | 205 | 2 | C3714644 | |
| Disease | amino acid measurement | ABCA12 SCN4A TXNDC16 ULK4 OR2F2 FAT4 ARRDC4 CPS1 ACKR4 SLC6A2 MMRN1 SUSD1 NISCH SENP6 | 3.02e-04 | 678 | 205 | 14 | EFO_0005134 |
| Disease | Gastrointestinal Stromal Sarcoma | 3.19e-04 | 47 | 205 | 4 | C3179349 | |
| Disease | Mammary Carcinoma, Human | STARD8 HNRNPL PTPRD KCNH1 KIT NRCAM DYNC2H1 AR NSUN6 NISCH LGR6 REPS2 | 3.32e-04 | 525 | 205 | 12 | C4704874 |
| Disease | Mammary Neoplasms, Human | STARD8 HNRNPL PTPRD KCNH1 KIT NRCAM DYNC2H1 AR NSUN6 NISCH LGR6 REPS2 | 3.32e-04 | 525 | 205 | 12 | C1257931 |
| Disease | Mammary Neoplasms | STARD8 HNRNPL PTPRD KCNH1 KIT NRCAM DYNC2H1 AR NSUN6 NISCH LGR6 REPS2 | 3.43e-04 | 527 | 205 | 12 | C1458155 |
| Disease | restless legs syndrome | 3.75e-04 | 49 | 205 | 4 | EFO_0004270 | |
| Disease | Gastrointestinal Stromal Tumors | 4.06e-04 | 50 | 205 | 4 | C0238198 | |
| Disease | Breast Carcinoma | STARD8 HNRNPL PTPRD KCNH1 KIT NRCAM DYNC2H1 AR NSUN6 NISCH LGR6 REPS2 | 4.13e-04 | 538 | 205 | 12 | C0678222 |
| Disease | X-23756 measurement | 4.74e-04 | 5 | 205 | 2 | EFO_0022126 | |
| Disease | ecosanoids measurement | 5.85e-04 | 55 | 205 | 4 | EFO_0020044 | |
| Disease | Neoplasm of the genitourinary tract | 6.01e-04 | 24 | 205 | 3 | cv:C0042065 | |
| Disease | VACTERL association (implicated_via_orthology) | 7.07e-04 | 6 | 205 | 2 | DOID:14679 (implicated_via_orthology) | |
| Disease | Sjogren-Larsson syndrome (implicated_via_orthology) | 7.07e-04 | 6 | 205 | 2 | DOID:14501 (implicated_via_orthology) | |
| Disease | bilirubin metabolic disorder (is_implicated_in) | 7.07e-04 | 6 | 205 | 2 | DOID:2741 (is_implicated_in) | |
| Disease | acute kidney failure (biomarker_via_orthology) | 8.66e-04 | 61 | 205 | 4 | DOID:3021 (biomarker_via_orthology) | |
| Disease | cerebral white matter volume change measurement, age at assessment | 9.52e-04 | 28 | 205 | 3 | EFO_0008007, EFO_0021499 | |
| Disease | Microcephaly | 1.23e-03 | 67 | 205 | 4 | C0025958 | |
| Disease | programmed cell death 1 ligand 2 measurement | 1.31e-03 | 8 | 205 | 2 | EFO_0008268 | |
| Disease | hypokalemic periodic paralysis (implicated_via_orthology) | 1.31e-03 | 8 | 205 | 2 | DOID:14452 (implicated_via_orthology) | |
| Disease | holoprosencephaly (is_implicated_in) | 1.31e-03 | 8 | 205 | 2 | DOID:4621 (is_implicated_in) | |
| Disease | Schizophrenia | LAMA1 CFAP65 SLC38A2 MET HSPA12A STXBP1 ULK4 KCNS3 ALDH3B1 CACNA1F HTR2A GRM4 SLC6A2 TLR3 UHMK1 | 1.37e-03 | 883 | 205 | 15 | C0036341 |
| Disease | creatinine measurement | USP45 CAND1 EVC SLC35D1 SLC35F3 PKD2 KCNS3 PLEC DENND5B DMGDH CACNA1S BTAF1 CPS1 AR CEMIP REPS2 | 1.67e-03 | 995 | 205 | 16 | EFO_0004518 |
| Disease | response to cytosine arabinoside | 1.84e-03 | 35 | 205 | 3 | EFO_0005655 | |
| Disease | creatine measurement | 1.99e-03 | 36 | 205 | 3 | EFO_0010472 | |
| Disease | Disproportionate short stature | 2.06e-03 | 77 | 205 | 4 | C0878659 | |
| Disease | Human papillomavirus infectious disease (is_marker_for) | 2.08e-03 | 10 | 205 | 2 | DOID:11166 (is_marker_for) | |
| Disease | Jeune thoracic dystrophy | 2.54e-03 | 11 | 205 | 2 | C0265275 | |
| Disease | granulosa cell tumor (is_marker_for) | 2.54e-03 | 11 | 205 | 2 | DOID:2999 (is_marker_for) | |
| Disease | 3-methylglutarylcarnitine (2) measurement | 2.54e-03 | 11 | 205 | 2 | EFO_0800074 | |
| Disease | gastrointestinal stromal tumor (is_implicated_in) | 2.54e-03 | 11 | 205 | 2 | DOID:9253 (is_implicated_in) | |
| Disease | Cystic Kidney Diseases | 2.54e-03 | 11 | 205 | 2 | C1691228 | |
| Disease | response to anticoagulant | 2.90e-03 | 41 | 205 | 3 | GO_0061476 | |
| Disease | congenital diaphragmatic hernia (implicated_via_orthology) | 3.03e-03 | 12 | 205 | 2 | DOID:3827 (implicated_via_orthology) | |
| Disease | Congenital myopathy (disorder) | 3.03e-03 | 12 | 205 | 2 | C0270960 | |
| Disease | Malignant neoplasm of breast | STARD8 HNRNPL PTPRD KCNH1 SLC35A2 KIT NRCAM DYNC2H1 PANX2 AR LHCGR NSUN6 NISCH ZNF75A LGR6 REPS2 | 3.56e-03 | 1074 | 205 | 16 | C0006142 |
| Disease | Short Rib-Polydactyly Syndrome | 3.56e-03 | 13 | 205 | 2 | C0036996 | |
| Disease | Diverticular Bleeding | 3.56e-03 | 13 | 205 | 2 | C4505353 | |
| Disease | glutaroyl carnitine measurement | 3.56e-03 | 13 | 205 | 2 | EFO_0021005 | |
| Disease | Diverticular Diseases | 3.56e-03 | 13 | 205 | 2 | C4317009 | |
| Disease | X-24588 measurement | 3.56e-03 | 13 | 205 | 2 | EFO_0800898 | |
| Disease | colon carcinoma (is_marker_for) | 3.56e-03 | 13 | 205 | 2 | DOID:1520 (is_marker_for) | |
| Disease | cleft lip | 3.85e-03 | 284 | 205 | 7 | EFO_0003959 | |
| Disease | Malformations of Cortical Development | 4.14e-03 | 14 | 205 | 2 | C1955869 | |
| Disease | phosphatidylcholine 36:5 measurement | 4.14e-03 | 14 | 205 | 2 | EFO_0010383 | |
| Disease | N-acetylglycine measurement | 4.14e-03 | 14 | 205 | 2 | EFO_0021002 | |
| Disease | Saldino-Noonan Syndrome | 4.14e-03 | 14 | 205 | 2 | C0036069 | |
| Disease | Majewski Syndrome | 4.14e-03 | 14 | 205 | 2 | C0024507 | |
| Disease | Cortical Dysplasia | 4.14e-03 | 14 | 205 | 2 | C0431380 | |
| Disease | polycystic kidney disease (implicated_via_orthology) | 4.14e-03 | 14 | 205 | 2 | DOID:0080322 (implicated_via_orthology) | |
| Disease | progesterone measurement | 4.14e-03 | 14 | 205 | 2 | EFO_0007004 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 4.28e-03 | 152 | 205 | 5 | DOID:0060041 (implicated_via_orthology) | |
| Disease | Osteosarcoma | 4.28e-03 | 47 | 205 | 3 | C0029463 | |
| Disease | Adenocarcinoma of large intestine | 4.57e-03 | 96 | 205 | 4 | C1319315 | |
| Disease | Non-steroidal anti-inflammatory and antirheumatic product use measurement | 4.75e-03 | 15 | 205 | 2 | EFO_0009935 | |
| Disease | Alopecia, Male Pattern | 4.75e-03 | 15 | 205 | 2 | C4083212 | |
| Disease | Neoplasm of uncertain or unknown behavior of bladder | 4.75e-03 | 15 | 205 | 2 | C0496930 | |
| Disease | Benign neoplasm of bladder | 4.75e-03 | 15 | 205 | 2 | C0154017 | |
| Disease | Carcinoma in situ of bladder | 4.75e-03 | 15 | 205 | 2 | C0154091 | |
| Disease | Androgenetic Alopecia | 4.75e-03 | 15 | 205 | 2 | C0162311 | |
| Disease | Female pattern alopecia (disorder) | 4.75e-03 | 15 | 205 | 2 | C0263477 | |
| Disease | cholestasis (biomarker_via_orthology) | 4.81e-03 | 49 | 205 | 3 | DOID:13580 (biomarker_via_orthology) | |
| Disease | hepatocellular carcinoma (is_marker_for) | 5.26e-03 | 301 | 205 | 7 | DOID:684 (is_marker_for) | |
| Disease | Squamous cell carcinoma of the head and neck | 5.69e-03 | 52 | 205 | 3 | C1168401 | |
| Disease | interleukin 12 measurement | 6.00e-03 | 53 | 205 | 3 | EFO_0004753 | |
| Disease | monoclonal gammopathy | 6.00e-03 | 53 | 205 | 3 | EFO_0000203 | |
| Disease | metabolite measurement | SLC38A2 ABHD1 ABCC2 DMGDH DPYS CYP4F2 REV3L CPS1 SLC7A6 CAPN11 | 6.04e-03 | 560 | 205 | 10 | EFO_0004725 |
| Disease | Seizures, Focal | 6.06e-03 | 104 | 205 | 4 | C0751495 | |
| Disease | Sjogren's syndrome (implicated_via_orthology) | 6.10e-03 | 17 | 205 | 2 | DOID:12894 (implicated_via_orthology) | |
| Disease | Eye Abnormalities | 6.10e-03 | 17 | 205 | 2 | C0015393 | |
| Disease | pre-eclampsia (biomarker_via_orthology) | 6.10e-03 | 17 | 205 | 2 | DOID:10591 (biomarker_via_orthology) | |
| Disease | leukemia | 6.65e-03 | 55 | 205 | 3 | C0023418 | |
| Disease | platelet measurement | 6.70e-03 | 315 | 205 | 7 | EFO_0005036 | |
| Disease | Carcinoma of bladder | 6.83e-03 | 18 | 205 | 2 | C0699885 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| YVISFVVPNQKRLTL | 611 | O60488 | |
| LYAQKLVTQPTLLSA | 41 | Q8IVW6 | |
| SFNVSIPYLQIRSIK | 196 | Q8N3I7 | |
| ALVAAFVVLQLPYSL | 251 | P46092 | |
| TYTIAVINALFLKAP | 241 | Q92556 | |
| EFILQKPLFTLNTYN | 526 | Q8NFR7 | |
| VVKLNPSLQTTTFYF | 36 | P0DMS8 | |
| SSQLLKIYTVVQFAL | 331 | Q6ZNB7 | |
| SVLLVVQKVYPRFAT | 291 | Q86UK0 | |
| PLALYAFSNSSQVVK | 361 | P43353 | |
| ANILRLFKIPQISYA | 166 | Q14833 | |
| VASALVPSQLIYNLI | 1586 | Q6V0I7 | |
| LSSAVNPLVYTLFNK | 371 | P28223 | |
| KVLLPQYSQETFIQI | 261 | O96020 | |
| IYAILQALDLQTPSF | 221 | Q5VUY0 | |
| AQLQTIGFVLYAVPK | 461 | Q9UMQ6 | |
| LFNYVATIPDNSIVL | 1276 | Q8WUJ3 | |
| LLVIYFPPLQKVFQT | 856 | P98194 | |
| NQISTAKYSVLTFLP | 71 | Q9NTI2 | |
| QFPKYIQDIVASTLK | 776 | Q06278 | |
| IVPKAAIFQTQTYLA | 226 | Q8NCT1 | |
| SYFTFQLQNIVKPLP | 226 | Q14627 | |
| LNAFTVTVPKDLYVV | 16 | Q9NZQ7 | |
| FLKAQQVQAPVELYS | 451 | Q9ULC6 | |
| QIAALFTVTVPKELY | 16 | Q9BQ51 | |
| NVALAQALTPYVFLS | 506 | Q8N3Y3 | |
| NTDKIISVFYTIFIP | 271 | Q13606 | |
| AVLVIYPTNQAVIAL | 126 | Q9UHI5 | |
| AVIALTFSNYVLQPL | 136 | Q9UHI5 | |
| VNSVFIPRKYLLNSV | 576 | Q6ZRR7 | |
| ILLSIPQLVFYTVND | 166 | Q9NPB9 | |
| VIVFIVTQLPYNIVK | 246 | Q9NPB9 | |
| LAVYKAFTVDSPVQQ | 111 | Q9H1A4 | |
| TFYRPDNILVKLNTT | 286 | D6REC4 | |
| IKSFQALPYVALLIA | 1321 | O60840 | |
| SKFNISIEPVIYVVQ | 206 | P23352 | |
| PLQYSAILTNKVVSV | 131 | Q8NGJ4 | |
| KIIAVFYTFVSPVLN | 271 | Q96RB7 | |
| DQALAVVYSVLTPFL | 271 | Q8NGY5 | |
| QKILTLVYSVTTPLF | 281 | Q8NGC9 | |
| PLSKKQEIFYTAIVN | 471 | Q9NRZ9 | |
| VTNSKVLLVLFYPIN | 601 | P22888 | |
| TVQLLVYAFPDQLTV | 106 | Q13477 | |
| FQVTYLPVQKSGIID | 171 | Q9Y697 | |
| AAIAFNVYVNTKPEI | 401 | P10721 | |
| TPTFVPYLIKVQALN | 811 | Q92823 | |
| NPYLKNSVTAREFLV | 706 | Q8NI17 | |
| IPDYAFQNLTSLVVL | 201 | Q9HBX8 | |
| LNASNLIYPIFVTDV | 26 | P13716 | |
| YNFVLQVAKTLAGIP | 796 | Q13201 | |
| YNPNKIFGVTTLDIV | 161 | P40926 | |
| SQIKVTFQPLTAVIY | 301 | Q6ZU64 | |
| AVTSTNAAKIFNLYP | 376 | Q14117 | |
| VKSLFYSQVNFTVPV | 1936 | Q5CZC0 | |
| PFYKITSEALLVTQQ | 531 | Q86VP6 | |
| VSTVFTVLQPALKYV | 1281 | Q96RV3 | |
| TFSIYLESVAILPQL | 121 | O43731 | |
| KFVALFYTIITPILN | 271 | Q8NGV0 | |
| YVQIFITVFQLPQKE | 221 | Q9H2C5 | |
| LLLNSSVPVDKYVFN | 871 | Q7Z5P9 | |
| ALAAVFQIISLVIYP | 116 | Q96FX8 | |
| LLVFNITKAPLQGYV | 331 | Q5H8C1 | |
| LSPNTQDVLIFKLYQ | 316 | Q01415 | |
| VFYVQTLQDPSKALV | 461 | Q96J66 | |
| YLKSLPRVQVESFNQ | 631 | Q9Y239 | |
| LPPVQLAQKYFQIFS | 561 | P52848 | |
| TAILVPYNVSFKTRQ | 231 | O95259 | |
| LLFTLYPNAAIIAKI | 2001 | Q5S007 | |
| TLSKLAAITVLQPFY | 406 | Q6P1A2 | |
| LVVALPITIIFNKFS | 396 | Q9BQ31 | |
| VNDIFTFVSPQLLKL | 331 | Q92887 | |
| RFYQLTKLLDSVQPI | 856 | P10275 | |
| AKPSQLVIVINIYSS | 591 | O43301 | |
| NKIISVFYTVVTPLL | 271 | Q8NGX0 | |
| PSVLQEKLISVFYAI | 266 | O95006 | |
| SYQPLQRKLFTAAVQ | 346 | Q8TEA1 | |
| SINNLKPGTVYVFQI | 501 | Q15375 | |
| QNPTVKALLIVAYSF | 66 | Q9NYM4 | |
| IPLFVQLLYSSVENI | 586 | P14923 | |
| PQAKNTTAFSVLYAV | 451 | Q9P2V4 | |
| FELTYVGPSQVIVKN | 326 | Q9UG01 | |
| DIYPSVSLQIQKNFA | 286 | Q96NX5 | |
| KFISLFYSIITPTLN | 276 | Q5JQS5 | |
| FVLFYVIPEVSQVTK | 291 | Q9NQ84 | |
| KPLQYSSIITDQFVA | 131 | P0C7T3 | |
| KVSSLFYTIIVPVLN | 271 | Q8NGG6 | |
| NKIISVLYTIIVPFF | 271 | Q8NGX9 | |
| NFTPILLQSSLKITY | 3816 | Q8NCM8 | |
| QIFQALFLYSVPNKV | 241 | Q9NWS6 | |
| IPLLTNFQVTKLFAE | 1461 | P31327 | |
| IIASIPIKFSANAVY | 3151 | Q4G0P3 | |
| PVVQIKTYQLLHSIF | 1866 | Q86XA9 | |
| IRQLFYSFVKIINPQ | 96 | Q96PB1 | |
| KTLFLEYQAVPVILS | 526 | Q96M89 | |
| LVYLQTQKVPFIINT | 461 | O14981 | |
| IKSFQALPYVALLIV | 1261 | Q13698 | |
| YLKNSFIPTEVSVLV | 406 | Q53R41 | |
| ALPTTFAVIENLKYL | 141 | P0DN25 | |
| SQVPQSKYAELLAII | 56 | O14519 | |
| TLFSPITQQLRYLLK | 86 | A6NJJ6 | |
| FVQSVLPYFVATKLA | 226 | Q53GQ0 | |
| KFLIQLYKAVTSQQP | 206 | Q6ZUT9 | |
| VLTQLVATYPQGFKV | 76 | P78329 | |
| KSLAFAYVPVQLSEV | 811 | Q9UI17 | |
| KVLNLSLEYNFVTPL | 591 | Q6UXX5 | |
| ILAKNYFSQVPVLAS | 746 | Q8NA54 | |
| VNSVLLFTILNPIYS | 191 | P14866 | |
| DKVIQATTYFLQKPV | 406 | P49356 | |
| ANQLYPFAISLIESV | 771 | Q14204 | |
| TFILDPFQYQLVIKN | 91 | O75881 | |
| VYRTASIPKNVFLAL | 101 | Q9NYL5 | |
| VLYKSLNPNLLAVVT | 731 | Q8N766 | |
| TAFALKAKVIYPINQ | 111 | P57679 | |
| TPGYTKLLQFIQNII | 221 | Q96EB1 | |
| TFSIYLESVAILPQL | 121 | P24390 | |
| PTSIKFKIQLVAVNY | 291 | Q9UJW0 | |
| LKTISPNNFTLAFIV | 746 | Q7Z3Z3 | |
| PLFSELLQNAVIYSI | 551 | Q9NZJ4 | |
| ALLIAQNSTPILYTI | 461 | Q68D06 | |
| NFLNVARTYIPNTKV | 16 | Q9P1Z2 | |
| TFSIYLESVAILPQL | 121 | P33947 | |
| TYIFIQIVALIPAAS | 151 | O43933 | |
| PQQIRKLFYVLSTLA | 526 | Q9BXW9 | |
| AYNAFLNKIQTVPVV | 1831 | Q5VU65 | |
| ILLVPVALIIFSYSQ | 206 | P59922 | |
| VPILLVTLVFTKNFA | 61 | Q96RD6 | |
| YNKIVSLLVSVLTPF | 266 | Q8NGT5 | |
| SQFTRNALPALLIYK | 226 | Q13371 | |
| NLVPQKTYSVKVLAF | 481 | P23468 | |
| LNQSYKIINFAPSLL | 26 | O15397 | |
| LASSKTVYTLFIIPQ | 66 | Q8NGY7 | |
| DSQIALVYTFVTPLL | 276 | Q8NGQ4 | |
| PVSFYQLLLQEVAKT | 206 | Q8TC99 | |
| KEVFNILQAAYVSKP | 311 | P08581 | |
| NSVYILFKVITVFLN | 91 | P59535 | |
| FVVVVSIINFKPLTY | 531 | P23975 | |
| YLTSLFEVLPQQVTI | 246 | P46939 | |
| YIKIPFQVSLNEISL | 546 | Q9BQF6 | |
| KQYSLNIILSVFAII | 141 | Q76EJ3 | |
| LYNSLTRNKEVFIPQ | 31 | P49589 | |
| IQKVFFLPLSNTILS | 171 | Q96DN5 | |
| IKLFYTSNIPIILQS | 281 | Q9H9S3 | |
| LIQKYFVSPTLFRVI | 1436 | P35499 | |
| YVLKPTFTKQQIANL | 191 | Q53GS9 | |
| IPLILKFFNQNILSY | 606 | Q9ULQ0 | |
| VTAVNLVLYLVVKPN | 51 | Q07326 | |
| ELTPLILATQKQFNY | 91 | P13804 | |
| VFQVAYVIIKAANAP | 116 | P25391 | |
| ALLIAQNSTPILYTI | 461 | Q7Z7L1 | |
| ALASLRNLYTPNVKV | 901 | Q9C0D5 | |
| AKESVLQFYPKANIV | 76 | Q9UBT2 | |
| IAYQFTDTPLQIKSV | 201 | O00267 | |
| AFNNVAITYPIQKVL | 41 | Q3SY17 | |
| AITYPIQKVLFRQQL | 46 | Q3SY17 | |
| SLKSILTNPLYVIFV | 281 | G3V0H7 | |
| IVVVNKSVLTNYRFP | 56 | Q9NTN3 | |
| VIKTLTEINIAFLPY | 126 | P61764 | |
| NIVLNFGIAVTYPTL | 316 | Q8IY50 | |
| TTTFLQIYQLLPKDQ | 661 | Q92502 | |
| PAALISIIQKGLQYV | 46 | Q9BZK7 | |
| QTLSAQLDLPKYTII | 676 | Q01826 | |
| ILKNFNPTVNYILSI | 156 | Q9UNL2 | |
| KYISLAVLVVQNASL | 36 | P78381 | |
| LPAATFQVTYQLKIL | 136 | P78381 | |
| SIFQVLLQSQPLVLY | 76 | Q96SE0 | |
| VIILLAPVQYFVATK | 466 | Q09428 | |
| IIQTADYPINLAAIK | 1186 | O75122 | |
| LITKPNFISTLSYAI | 81 | A5YKK6 | |
| AEVKSLIQYFSPVIQ | 1386 | Q96JI7 | |
| NLNTDFVSLRQVPYK | 91 | Q6P2D0 | |
| QVYQAFKLLTADPKV | 341 | Q96I99 | |
| NYSNLVFLGIVVSKP | 36 | P35789 | |
| TVIALTPELKVFYQS | 486 | Q8NHH1 | |
| LPLVFIVSQQATYEA | 271 | Q9P2K2 | |
| TVAALVALVLNVFYP | 1296 | O94966 | |
| VALVLNVFYPLVSQS | 1301 | O94966 | |
| FQQLAPLYEIVIFTS | 181 | Q3ZCQ8 | |
| NKYLQLTRNSFALVP | 466 | O15455 | |
| EQILTQYTTFVKPAF | 181 | Q9HA47 | |
| YTNARKQLLISAVPA | 666 | Q70EL2 | |
| TSVIQFYPSKFVLIT | 221 | Q7Z3J2 | |
| NIVNALASVPKFYVQ | 171 | Q96LT9 | |
| PTQFYIALKLIAAAQ | 106 | Q8NFH8 | |
| LVLDFQSLYPSIVIA | 2611 | O60673 | |
| VLLSIFIYNASKPQV | 366 | Q9BS91 | |
| FPSLKYLVVNDNQIS | 306 | Q15813 | |
| IKLFYTSNIPIILQS | 281 | P61619 | |
| LFAVALPQLLAKYSV | 566 | Q8N3U4 | |
| FIFNSQTVYAVPILI | 286 | Q96QD8 | |
| FISKQYVTSLLLNEP | 541 | P42226 | |
| ISSYQVLVLPLALQS | 616 | Q6UWL2 | |
| VTAKTAFLFILPQYN | 41 | Q15035 | |
| FQSLKSILTNPLYVI | 326 | Q9NPD5 | |
| YPRKNLFLVEVTQLT | 81 | O60667 | |
| KAPALSILLYVQAFQ | 1341 | Q9Y2I1 | |
| FLQAIPAVYQKLSIQ | 506 | Q9GZR1 | |
| VTFKFILANRLYPVS | 321 | Q15904 | |
| FPQISNATDRKYLVI | 91 | A8MWL6 | |
| LQLVTYKAQLEPVAS | 1421 | Q15149 | |
| QFQPLKLIRYVTTFD | 456 | Q13563 | |
| NYSNLVFLGITVSKP | 36 | Q68DY1 | |
| AIIAITFANYIIQPS | 141 | Q92536 | |
| LIPQNKYIQLFTTIL | 91 | Q6GV28 | |
| ASIIFVTLQYNVTLP | 46 | Q15629 | |
| QNSKYPILFLFLLIT | 646 | Q8NET8 | |
| LNFSFIIIPQFTVAK | 466 | Q6UXY8 | |
| VVNIFLVAKALLSYP | 381 | Q9H598 | |
| KSLPQTERIYFQVFL | 156 | Q8TCF1 | |
| APEQFISQVTVLKYF | 561 | Q9NYY3 | |
| YALNVPISVKQEITF | 106 | Q9UQR1 | |
| NYETVISLALFVLPK | 26 | Q96N20 | |
| TSQYFFITPKLLQNL | 1046 | Q8IY18 | |
| IFASKAVVNAAIPAY | 261 | Q8TAS1 | |
| PIVLLNTLLFFNTKY | 1376 | Q5VZL5 | |
| ITLSAFEAIIQYPIL | 906 | Q96C45 | |
| TPLALAYIVFVLTLN | 576 | P16473 | |
| SFYALSAILNKPLIT | 641 | P16473 | |
| VSNSKILLVLFYPLN | 656 | P16473 | |
| VPLRYVKFQNVNSVT | 231 | O43396 | |
| TAQIVKVLNLYTPVN | 1776 | Q9Y4I1 | |
| LSAVQIIKILNSYTP | 1661 | Q9NQX4 |